Generic Omnicef is available in the form of capsules and an oral suspension (liquid) and comes in several strengths. A few of the companies that manufacture generic Omnicef include Lupin Pharmaceuticals, Sandoz Pharmaceuticals, and Teva Pharmaceuticals. All generic Omnicef products currently available have an "AB" rating, meaning that they should be equivalent to the brand-name medication.
Omnicef® (cefdinir) is a prescription medication that has been licensed to treat several types of bacterial infections, including:
- Middle ear infection (otitis media)
- Sinus infection (sinusitis)
- Skin infection (such as cellulitis)
- Throat infection (such as strep throat).
Omnicef is manufactured by Abbott Laboratories. However, the patents for Omnicef have expired, and generic versions of this medication are now available.
Generic Omnicef comes in the following strengths and forms:
- Cefdinir 300 mg capsules
- Cefdinir oral suspension (liquid) 125 mg/5 mL -- each teaspoon (5 mL) containing 125 mg of cefdinir
- Cefdinir oral suspension 250 mg/5 mL -- each teaspoon (5 mL) containing 250 mg of cefdinir.
Generic Omnicef is made by the following manufacturers:
- DAVA Pharmaceuticals
- Lupin Pharmaceuticals
- Sandoz Pharmaceuticals
- Teva Pharmaceuticals.
All generic medications must have certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generics are equivalent to the brand-name medications and assigns each generic a rating. An "AB" rating means that the FDA has determined that a generic medication is equivalent to a brand-name medication. All of the generic cefdinir versions currently available have an "AB" rating, meaning they should be equivalent to Omnicef.
However, generic medications are allowed to have different inactive ingredients than the brand-name medication. These inactive ingredients might include fillers, dyes, or other ingredients that may cause problems for people with allergies or sensitivities.